With a market cap of $125.3 billion, Stryker Corporation (SYK) is a medical technology company that develops and markets ...

Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be ...

Stryker remains a high-quality MedTech compounder despite a rare Q1 miss driven by a temporary cyber disruption. Learn more ...

Stryker stock looks undervalued with a 13% discount to fair value, a strong EPS growth outlook, and dividend potential. Click ...

Is SYK a good stock to buy? We came across a bullish thesis on Stryker Corporation on MaxDividends’s Substack by Serhio MaxDividends. In this article, we will summarize the bulls’ thesis on SYK.

Stryker Corporation (NYSE:SYK) ranks among the best set-it-and-forget-it stocks to buy right now. On June 5, Leerink reduced ...

In a report released yesterday, from Wells Fargo maintained a Buy rating on Stryker, with a price target of $418.00. The company’s shares closed yesterday at $326.85. TipRanks Welcomes a New ETF – ...

Stryker Corp. closed 18.56% short of its 52-week high of $404.87, which the company reached on July 23rd. Supported by world-class markets data from Dow Jones and FactSet, and partnering with ...

Get the live share price of Stryker Corporation (SYK), including intraday charts, historical performance, key financials, and ...

Lawsuits against Stryker Corp. over a cyberattack have been dismissed, but the door remains open for refiling. Stryker claims ...